Artivion, Inc. - SIC # 8099 - HEALTH AND ALLIED SERVICES, NOT ELSEWHERE CLASSIFIED

Ticker Exchange SIC # Website Latest Ticker
AORT New York 8099 artivion.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Artivion, Inc.

Artivion Announces Agreements to Exchange $95 Million in Principal Amount of its 4.250% Convertible Notes Due 2025 for Common Stock - May 14th, 2025 8:01 pm
Artivion Reports First Quarter 2025 Financial Results - May 5th, 2025 8:05 pm
Artivion Announces Presentation of New Clinical Data from NEXUS TRIOMPHE IDE Trial at the 105th American Association for Thoracic Surgery (AATS) Annual Meeting - May 5th, 2025 11:00 am
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2025 Financial Results - Apr 21st, 2025 8:10 pm
Investors in Artivion (NYSE:AORT) have seen returns of 15% over the past year - Apr 14th, 2025 12:58 pm
Do Options Traders Know Something About Artivion (AORT) Stock We Don't? - Mar 24th, 2025 4:20 pm
Artivion to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference - Mar 4th, 2025 9:05 pm
Artivion Full Year 2024 Earnings: EPS Misses Expectations - Mar 4th, 2025 10:31 am
Down -18.58% in 4 Weeks, Here's Why Artivion (AORT) Looks Ripe for a Turnaround - Feb 27th, 2025 2:35 pm
Earnings Miss: Artivion, Inc. Missed EPS And Analysts Are Revising Their Forecasts - Feb 27th, 2025 10:54 am
Artivion price target lowered to $32 from $34 at Needham - Feb 26th, 2025 3:01 pm
Artivion Reports Fourth Quarter and Full Year 2024 Financial Results - Feb 24th, 2025 9:05 pm
Should You Investigate Artivion, Inc. (NYSE:AORT) At US$28.26? - Feb 24th, 2025 5:22 pm
Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2024 Financial Results - Feb 10th, 2025 9:10 pm
Estimating The Fair Value Of Artivion, Inc. (NYSE:AORT) - Feb 4th, 2025 10:17 am
Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 61st Society of Thoracic Surgery Annual Meeting - Jan 27th, 2025 1:00 pm
3 US Stocks Estimated To Be Trading Below Their Intrinsic Value In January 2025 - Jan 14th, 2025 2:03 pm
Artivion Granted FDA Humanitarian Device Exemption for the AMDS Hybrid Prosthesis - Dec 9th, 2024 1:00 pm
Returns On Capital Are Showing Encouraging Signs At Artivion (NYSE:AORT) - Nov 30th, 2024 2:08 pm
Artivion Third Quarter 2024 Earnings: Beats Expectations - Nov 9th, 2024 12:03 pm